ArticleJournal of cardiology cases2020
Cardiac angiosarcoma: A diagnostic and therapeutic challenge.
Article in Journal of cardiology cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 21 citations in OpenAlex.
- Demographics and factors influencing mortality among cardiac angiosarcoma patients and genomic studies correlation for future personalized management.Proceedings (Baylor University. Medical Center) · 2026Article
- Primary cardiac angiosarcoma: From pathogenesis to therapeutic strategies.Medical oncology (Northwood, London, England) · 2026Review
- Article
- The bleeding heart: A case of cardiac angiosarcoma presenting with pulmonary hemorrhage and hemoptysis.Radiology case reports · 2025Article
- Angiosarcoma: a 10-year retrospective study from a high-volume UK regional referral centre.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025Article
- Primary Pericardial Angiosarcoma Complicated by Constrictive Pericarditis.Arquivos brasileiros de cardiologia · 2025Article
- Chest Pain and ST-Segment Elevation: Angiosarcoma Discovered With Coronary Angiography.JACC. Case reports · 2024Article
- Minimally-Invasive Approach in the Setting of a Malignant Primary Cardiac Tumor.The Thoracic and cardiovascular surgeon reports · 2024Article
- MicroRNAs and angiosarcoma: are there promising reports?Frontiers in oncology · 2024Review
- Primary cardiac angiosarcoma presenting with haemoptysis.BMJ case reports · 2023Article
- Outcomes of Surgery in Cardiac Angiosarcoma: A Multi-Institutional Study From the National Cancer Database.JACC. CardioOncology · 2023Article
- Cardiac angiosarcoma: a formidable challenge.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2023Article
- Intracardiac biopsy of cardiac tumors with echocardiographic guidance: Case report.Frontiers in cardiovascular medicine · 2023Article
- A case report of primary cardiac angiosarcoma withFrontiers in oncology · 2022Article
- Three-dimensional transesophageal echocardiography guided endomyocardial biopsy in diagnosis of cardiac tumor.Cardiology journal · 2022Article
- Case Report: An Unusual Cause for Recurrent Hemopericardium in a Patient With Dyspnea.Frontiers in cardiovascular medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac angiosarcomas are a rare group of soft tissue sarcomas, characterized by aggressive local growth and early spread. Because this is an uncommon disease, there is currently no standard treatment approach. When localized, surgery appears to lead to the best outcomes, but this can be technically challenging and not always feasible. Upfront chemoradiotherapy provides an alternative that may shrink the tumor to enable definitive surgical resection. We report a case of primary cardiac angiosarcoma with a complete metabolic and pathological response after upfront chemoradiotherapy with paclitaxel, who then underwent surgery, as a potential treatment option for patients with this rare condition. <
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.